We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04268771
Brief Title: A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products (RI-01-007)

First Submitted : January 31, 2020
First Submitted that Met QC Criteria : February 11, 2020
First Posted : February 13, 2020

Last Update Submitted that Met QC Criteria : April 6, 2022
Last Update Posted : April 7, 2022